Cargando…
Estimation of the risk of secondary malignancy arising from whole-breast irradiation: comparison of five radiotherapy modalities, including TomoHDA
The risk of secondary cancer from radiation treatment remains a concern for long-term breast cancer survivors, especially those treated with radiation at the age younger than 45 years. Treatment modalities optimally maximize the dose delivery to the tumor while minimizing radiation doses to neighbor...
Autores principales: | Han, Eun Young, Paudel, Nava, Sung, Jiwon, Yoon, Myonggeun, Chung, Weon Kuu, Kim, Dong Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008415/ https://www.ncbi.nlm.nih.gov/pubmed/27027239 http://dx.doi.org/10.18632/oncotarget.8392 |
Ejemplares similares
-
Hybrid Tomo‐Helical and Tomo‐Direct radiotherapy for localized prostate cancer
por: Karaca, Sibel, et al.
Publicado: (2021) -
Feasibility of hybrid TomoHelical- and TomoDirect-based volumetric gradient matching technique for total body irradiation
por: Hong, Chae-Seon, et al.
Publicado: (2019) -
Risk of second cancer from scattered radiation of intensity-modulated radiotherapies with lung cancer
por: Kim, Dong Wook, et al.
Publicado: (2013) -
Risk of secondary cancers from scattered radiation during intensity-modulated radiotherapies for hepatocellular carcinoma
por: Kim, Dong Wook, et al.
Publicado: (2014) -
Intensity-modulated Total Body Irradiation (TBI) with TomoDirect™
por: Salz, Henning, et al.
Publicado: (2015)